// App-Quantinova.ai

513 : RAS mutation prevalence among patients with metastatic colorectal cancer: A meta-analysis of real-world data.

Researchers

Presenter

  • George Kafatos

Principal Investigators

  • Kimberly Lowe

  • Sophie Jenkins-Anderson

  • Tamer Garawin

  • Zuzana Traugottov

  • Antonios Bilalis

  • Edit Molnr

  • Karolina Wieruszewska-Kowalczyk

  • Daniela Niepel

  • J. Han van Krieken

Medical Centers

  • Amgen, Ltd., Uxbridge, United Kingdom

  • Amgen, Seattle, WA

  • Adelphi Values, Bollington, United Kingdom

  • Amgen Inc, Thousand Oaks, CA

  • Gyncentrum, Prague, Czech Republic

  • Amgen, Athens, Greece

  • Amgen, Budapest, Hungary

  • Amgen, Warsaw, Poland

  • Amgen, Vienna, Austria

  • Radboud University Medical Center, Njmegen, Netherlands

Locations

  • United Kingdom

  • United States

  • Czech Republic

  • Greece

  • Hungary

  • Poland

  • Austria

  • Netherlands

Companies

  • Amgen Ltd

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • RAS mutation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved